BridgeBio Pharma’s acoramidis shows improved survival data, boosting approval chances. Read why BBIO stock could see gains if ...

Profile-based personalisation ... These advancements empower organisations on their journey to building proactive, positive security... at 10:05 Pfizer Invites Public to View and Listen to Webcast of ...

Analysts have set 12-month price targets for BioNTech, revealing an average target of $132.24, a high estimate of $171.00, ...

Leerink Partners analyst David Risinger has reiterated their bullish stance on CNTA stock, giving a Buy rating yesterday. David Risinger has ...

GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an ...

With a 26-year track record of success, it has been engaged in a systematic effort to highlight Greece's profile to a global ...

With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc (NYSE: PFE) reported its third quarter revenue grew 14% ...

Francine Metelo Masega-A-Gulema from Pfizer highlighted that accessibility and infrastructure ... The conference was hosted ...

The pink, blue and purple holiday cups featuring Doodle characters in snowy scenes will be available starting on Nov. 18.

Western nations remain startlingly unprepared for a new phase of terror enabled by individually targeted drones.

Apple’s ( AAPL) latest MacBook Pro line of laptops is here, and it packs a serious punch for users looking for a portable powerhouse that can handle everything from photo and video editing to gaming ...

Influenza causes 140,000 to 710,000 hospitalisations and 12,000 to 52,000 deaths in the US every year, as well as economic losses of around $25 billion a year, according to Pfizer.